Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Mood Disorder With Psychotic Features”

22 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 22 results

Large-scale testing (Phase 3)Study completedNCT00128505
What this trial is testing

An International Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Major Depressive DisorderPsychotic Disorders
Corcept Therapeutics 104
Large-scale testing (Phase 3)Study completedNCT00128479
What this trial is testing

A United States Study of the Safety and Tolerability of Corlux for Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Major Depressive DisorderPsychotic Disorders
Corcept Therapeutics 443
Testing effectiveness (Phase 2)Study completedNCT00844922
What this trial is testing

Safety of Org 34517 900 mg in Patients Who Received Org 34517 in a Previous Trial (Study 28133/P05842)

Who this might be right for
Depressive DisordersPsychotic DisordersDepression
Merck Sharp & Dohme LLC 16
Large-scale testing (Phase 3)Study completedNCT00340379
What this trial is testing

Ziprasidone vs. Sertraline/Haloperidol in Psychotic Depression

Who this might be right for
Affective Disorders
Duke University 72
Not applicableStudy completedNCT00531518
What this trial is testing

Early Detection and Intervention for the Prevention of Psychosis

Who this might be right for
SchizophreniaBipolar DisorderDepression+1 more
MaineHealth 292
Testing effectiveness (Phase 2)Study completedNCT00226278
What this trial is testing

Safety Study of ORG 34517 for Major Depression With Psychotic Features

Who this might be right for
Major Depressive DisorderPsychotic Disorders
Weill Medical College of Cornell University 25
Large-scale testing (Phase 3)Study completedNCT00130676
What this trial is testing

A United States Study of Corlux for Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Major Depressive DisorderPsychotic Disorders
Corcept Therapeutics 257
Not applicableActive Not RecruitingNCT05877716
What this trial is testing

EPI-MINN: Targeting Cognition and Motivation - National

Who this might be right for
PsychosisPsychosis Nos/OtherSchizophrenia+8 more
University of Minnesota 200
Not applicableStudy completedNCT05965232
What this trial is testing

FIbrosis and Steatosis in Patients With Psychiatric Illness

Who this might be right for
Severe Bipolar I Disorder (Diagnosis)Bipolar I Disorder, Most Recent Episode Mixed, in RemissionDepression Psychotic Feature+1 more
Centre Hospitalier Esquirol 385
Not applicableUnknownNCT01888627
What this trial is testing

Integrated Care in Psychotic Disorders With Severe Mental Illness

Who this might be right for
SchizophreniaSchizophreniform DisorderSchizoaffective Disorder+4 more
Universitätsklinikum Hamburg-Eppendorf 400
Large-scale testing (Phase 3)Study completedNCT00208156
What this trial is testing

A United States Extension Study of Corlux for Recurrent Psychotic Symptoms in Psychotic Major Depression

Who this might be right for
Depressive Disorder, Major
Corcept Therapeutics 87
Testing effectiveness (Phase 2)Study completedNCT01731119
What this trial is testing

Study of Lurasidone in Treating Antipsychotic Naive or Quasi-Naive Children and Adolescents

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+10 more
University of North Carolina, Chapel Hill 9
Not applicableStudy completedNCT01866098
What this trial is testing

Naltrexone for Antipsychotic-Induced Weight Gain

Who this might be right for
SchizophreniaSchizoaffective DisorderSchizophreniform Disorder+2 more
Yale University 144
Not applicableStudy completedNCT01075295
What this trial is testing

Prevention of Weight Gain in Early Psychoses

Who this might be right for
Schizophreniform DisorderBipolar I DisorderBipolar II Disorder+5 more
Centre for Addiction and Mental Health 70
Not applicableStudy completedNCT00179062
What this trial is testing

Effects of Risperidone and Olanzapine on Patients With Schizophrenia, Schizoaffective Disorder, Major Depression or Bipolar Disorder

Who this might be right for
SchizophreniaSchizoaffective DisorderDepressive Disorder, Major+1 more
Vanderbilt University 300
Not applicableEnded earlyNCT01310140
What this trial is testing

Risks for Insulin Resistance and Metabolic Syndrome Between Major Depressive Disorder (MDD) or MDD With Psychotic Features

Who this might be right for
Major Depressive DisorderMajor Depressive Disorder w/ Psychotic FeaturesMetabolic Syndrome
Massachusetts General Hospital 14
Not applicableStudy completedNCT04874974
What this trial is testing

Feasibility of a Novel Process-based Treatment for Patients With Psychosis

Who this might be right for
SchizophreniaSchizotypal DisorderDelusional Disorder+10 more
Max-Planck-Institute of Psychiatry 37
Post-approval studies (Phase 4)Study completedNCT04004416
What this trial is testing

Multi-modal Assessment of Gamma-aminobutyric Acid (GABA) Function in Psychosis

Who this might be right for
SchizophreniaBipolar DisorderHealthy+4 more
University of Michigan 143
Large-scale testing (Phase 3)Study completedNCT00035321
What this trial is testing

The Study of Olanzapine Plus Fluoxetine in Combination for Treatment of Treatment Resistant Depression

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 600
Testing effectiveness (Phase 2)Study completedNCT00212797
What this trial is testing

Determine the Efficacy and Safety of 2 Doses of Org 34517 as Adjunctive Therapy in Subjects With Psychotic Major Depression (28130)(P05845)

Who this might be right for
DepressionDepressive DisordersPsychotic Disorders
Merck Sharp & Dohme LLC 273
Load More Results